These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3488194)

  • 1. Analysis of the relationship between ampicillin resistance and beta-lactamase production in Branhamella catarrhalis.
    Stobberingh EE; van Eck HJ; Houben AW; van Boven CP
    Drugs; 1986; 31 Suppl 3():23-7. PubMed ID: 3488194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Branhamella catarrhalis: antibiotic sensitivities and beta-lactamases.
    Stobberingh EE; Davies BI; van Boven CP
    J Antimicrob Chemother; 1984 Jan; 13(1):55-64. PubMed ID: 6607919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases.
    Philippon A; Riou JY; Guibourdenche M; Sotolongo F
    Drugs; 1986; 31 Suppl 3():64-9. PubMed ID: 3015547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.
    Liljequist BO; Gezelius L
    Eur J Clin Microbiol; 1986 Dec; 5(6):615-21. PubMed ID: 3492374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel beta-lactamase from Branhamella catarrhalis.
    Hoi-Dang AB; Brive-Le Bouguenec C; Barthelemy M; Labia R
    Ann Microbiol (Paris); 1978 Oct; 129 B(3):397-406. PubMed ID: 311606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoelectric focusing of beta-lactamases from sputum and middle ear isolates of Branhamella catarrhalis recovered in the United States.
    Nash DR; Wallace RJ; Steingrube VA; Shurin PA
    Drugs; 1986; 31 Suppl 3():48-54. PubMed ID: 3488197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The beta-lactamases of Moraxella (Branhamella) catarrhalis isolated from Danish children.
    Ejlertsen T; Skov R
    APMIS; 1996; 104(7-8):557-62. PubMed ID: 8920809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the beta-lactamases of Branhamella catarrhalis by clavulanic acid and other inhibitors.
    Farmer T; Reading C
    Drugs; 1986; 31 Suppl 3():70-8. PubMed ID: 3488199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmid-mediated beta-lactamase in Branhamella catarrhalis.
    Kamme C; Eliasson I; Knutson BK; Vang M
    Drugs; 1986; 31 Suppl 3():55-63. PubMed ID: 3488198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic susceptibility of beta-lactamase-producing strains of Branhamella (Neisseria) catarrhalis.
    Doern GV; Siebers KG; Hallick LM; Morse SA
    Antimicrob Agents Chemother; 1980 Jan; 17(1):24-9. PubMed ID: 6766292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-lactamase patterns and betalactam/clavulanic acid resistance in Escherichia coli isolated from fecal samples from healthy volunteers.
    Gulay Z; Bicmen M; Amyes SG; Yulug N
    J Chemother; 2000 Jun; 12(3):208-15. PubMed ID: 10877515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of beta-lactamases in Branhamella catarrhalis.
    Slocombe B
    Drugs; 1986; 31 Suppl 3():79-81. PubMed ID: 3488200
    [No Abstract]   [Full Text] [Related]  

  • 13. Classification of beta-lactamases from Branhamella catarrhalis in relation to penicillinases produced by other bacterial species.
    Labia R; Barthelemy M; Le Bouguennec CB; Buu Hoi-Dang Van A
    Drugs; 1986; 31 Suppl 3():40-7. PubMed ID: 3488196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfer of beta-lactamase production in Branhamella catarrhalis.
    Kamme C; Vang M; Ståhl S
    Scand J Infect Dis; 1983; 15(2):225-6. PubMed ID: 6603655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the plasmid-mediated beta-lactamase in Branhamella catarrhalis, with special reference to substrate affinity.
    Eliasson I; Kamme C
    J Antimicrob Chemother; 1985 Feb; 15(2):139-49. PubMed ID: 3872294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase producing microorganisms. Results with the use of microdilution broth method].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
    Jpn J Antibiot; 1990 Jul; 43(7):1214-24. PubMed ID: 2232151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchopulmonary infection due to Branhamella catarrhalis.
    McLeod DT; Ahmad F; Power JT; Calder MA; Seaton A
    Br Med J (Clin Res Ed); 1983 Nov; 287(6403):1446-7. PubMed ID: 6416451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Susceptibility of Branhamella catarrhalis to antibiotics].
    Leszczyńska K; Jakoniuk P; Sacha PT; Zalewska M; Wieczorek P
    Med Dosw Mikrobiol; 2004; 56(3):231-7. PubMed ID: 15773499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amoxycillin-clavulanic acid combination in bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis. Preliminary report.
    Thornley PE; Aitken JM; Nichol GM; Slevin NJ
    Drugs; 1986; 31 Suppl 3():113-4. PubMed ID: 3525087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute otitis media caused by Branhamella catarrhalis: biology and therapy.
    Van Hare GF; Shurin PA; Marchant CD; Cartelli NA; Johnson CE; Fulton D; Carlin S; Kim CH
    Rev Infect Dis; 1987; 9(1):16-27. PubMed ID: 3493519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.